Tirzepatide is a medication that helps people with type 2 diabetes and those trying to lose weight
The goal is finding your personal maximum effective dosethe level where you achieve meaningful weight loss with side effects you can tolerate, not necessarily reaching 2.4 mg
Amid the Biden administrations recent proposal to expand obesity drug coverage under Medicare and Medicaid, experts at Real Chemistry examined which state Medicaid programs currently cover GLP-1s approved to treat obesity and how much they are spending
Furthermore, published clinical trial programs, including large-scale metabolic studies, report that tirzepatide 10mg is associated with measurable, dose-dependent changes in glucose handling, insulin secretion dynamics, lipid parameters, and appetite-related biomarkers
This is why GLP1-based drugs like Ozempic and Wegovy are prescribed to help manage type 2 diabetes and aid in weight loss